About
RAPT Therapeutics is a clinical-stage biopharmaceutical company focused on developing allosteric inhibitors that modulate critical intracellular signaling pathways for the treatment of cancer and autoimmune diseases.
Explore RAPT Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.